תאריך רישום: February 5, 1981

מסלול הגשה: אחר

יצרן: TARO PHARMACEUTICALS INDUSTRIES, ISRAEL

בעל רישום: TARO PHARMACEUTICAL INDUSTRIES LTD

N05AC02 :ATC Code

תאריך רישום: October 10, 1985

מסלול הגשה: אחר

יצרן: TARO PHARMACEUTICALS INDUSTRIES, ISRAEL

בעל רישום: TARO PHARMACEUTICAL INDUSTRIES LTD

N05AC02 :ATC Code

תאריך רישום: September 15, 1974

מסלול הגשה: מולקולה חדשה

יצרן: TEVA PHARMACEUTICAL INDUSTRIES LTD, ISRAEL

בעל רישום: TEVA ISRAEL LTD

N04BA01 :ATC Code

4.1 Therapeutic indications For the relief of symptoms associated with Parkinson’s disease.

תאריך רישום: December 6, 2007

מסלול הגשה: תכשיר גנרי

יצרן: RECKITT BENCKISER HEALTHCARE (UK) LIMITED

בעל רישום: RECKITT BENCKISER (NEAR EAST) LTD

M01AE01 :ATC Code

4.1 Therapeutic indications For the reduction of fever and relief of mild to moderate pain. For infants and children aged 3 months to 12 years (i.e. weighing about 40 kg).

תאריך רישום: June 6, 1999

מסלול הגשה: מולקולה חדשה

יצרן: BAXTER HEALTHCARE S.A., IRELAND

בעל רישום: BAXTER HEALTHCARE DISTRIBUTION LTD., ISRAEL

B05AA05 :ATC Code

4.1 Therapeutic Indications Extraneal is recommended as a once daily replacement for a single glucose 4.4 Special Warnings and Precautions for Use exchange as part of a continuous ambulatory peritoneal dialysis (CAPD) or • Patients with diabetes mellitus often need additional insulin in order to automated peritoneal dialysis (APD) regimen for the treatment of chronic renal maintain glycaemic control during Peritoneal Dialysis (PD). Transfer from failure, particularly for patients who have lost ultrafiltration on glucose solutions, glucose based PD solution to Extraneal may necessitate an adjustment of the because it can extend time on CAPD therapy in such patients. usual insulin dosage. Insulin can be administered intraperitoneally.

תאריך רישום: May 2, 2007

מסלול הגשה: מולקולה חדשה

יצרן: BAUSCH & LOMB INCORPORATED, USA

בעל רישום: TEVA ISRAEL LTD

S01BA14 :ATC Code